ArticleOncoTargets and therapy2016

Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study.

Sicheng Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.